Results 211 to 220 of about 61,450 (241)
Some of the next articles are maybe not open access.
Latent Tuberculosis: Is There a Role for Thioridazine?
Recent Patents on Anti-Infective Drug Discovery, 2011Approximately 1/3 of the world's population is infected with Mycobacterium tuberculosis. In the vast majority of cases this results in latent not active disease. Latent disease is defined as a positive reaction to tuberculin antigens but without any further clinical symptoms.
openaire +2 more sources
Rifapentine for the treatment of latent tuberculosis
Expert Review of Clinical Pharmacology, 2016The goal of this article is to review the use of rifapentine in the treatment of latent tuberculosis infection (LTBI). Controlling LTBI is an important part of the global strategy to end the spread of tuberculosis. Rifapentine's potent sterilizing effect against Mycobacterium tuberculosis combined with its long half-life make it an attractive LTBI ...
Eric F, Egelund, Charles A, Peloquin
openaire +2 more sources
Treatment of latent tuberculosis infection
Seminars in Respiratory Infections, 2003Treatment of latent tuberculosis infection (LTBI) is considered an essential component of TB control programs in several industrialized countries and is being used in selected situations in developing countries. In 2000, the American Thoracic Society (ATS) and Centers for Disease Control and Prevention (CDC) published new recommendations on the ...
openaire +2 more sources
Spectrum of latent tuberculosis — existing tests cannot resolve the underlying phenotypes
Nature Reviews Microbiology, 2010Madhukar Pai, Pai Madhukar
exaly
Latent Mycobacterium tuberculosis Infection
New England Journal of Medicine, 2015Alberto Matteelli +2 more
exaly
Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
New England Journal of Medicine, 2011C Horsburgh +2 more
exaly
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults
New England Journal of Medicine, 2018Hamdan Al-Jahdali +2 more
exaly